Newsroom

Sorted by: Latest
-

EmPOWER AI London di Bidgely riunisce vari leader per mappare il futuro dell'elettrificazione, la flessibilità dei carichi, l'esperienza clienti e l'accessibilità energetica

LOS ALTOS, Calif.--(BUSINESS WIRE)--Bidgely porta il suo tour di approfondimenti globali a Londra dal 10 al 12 giugno, segnando la prossima tappa vitale nella sua serie di conferenze di punta EmPOWER AI. Parte di un tour internazionale che spazia da Toronto a New York, il forum di Londra serve da hub attivo e collaborativo per i rivenditori di energia pronti ad assumere un ruolo attivo, piuttosto che passivo, di fronte all'aumento dell'elettrificazione, alla flessibilità critica dei carichi, al...
-

Bidgelys „EmPOWER AI London“ bringt Führungskräfte zusammen, um die Zukunft der Elektrifizierung, der Lastflexibilität, des Kundenerlebnisses und der Erschwinglichkeit von Energie zu gestalten

LOS ALTOS, Kalifornien--(BUSINESS WIRE)--Bidgely bringt seine „Global Insights Tour“ vom 10. bis 12. Juni nach London und markiert damit die nächste wichtige Station seiner renommierten Konferenzreihe EmPOWER AI. Als Teil einer internationalen Tournee, die Toronto und New York umfasst, dient das Londoner Forum als aktiver, kooperativer Knotenpunkt für Energieversorger, die bereit sind, die zunehmende Elektrifizierung, die entscheidende Lastflexibilität, das Kundenerlebnis der nächsten Generatio...
-

InterSystems IntelliCare torna-se o primeiro EHR nativo de IA a obter a certificação do regulamento de dispositivos médicos da UE

BOSTON--(BUSINESS WIRE)--A InterSystems, um fornecedor de tecnologia de dados criativos que alimenta mais de um bilhão de registros de saúde em todo o mundo, anunciou hoje que suas soluções de registro eletrônico de saúde (EHR) foram certificadas como Dispositivos Médicos de Classe sob a certificação de Regulamento (MDR) sob o Regulamento (UE) 2017/745. Esta aprovação marca o primeiro EHR nativo de IA totalmente unificado a obter a certificação MDR Classe IIa na União Europeia. Esta certificaçã...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Equity Income UCITS ETF 28.05.2026 FGBL.LN IE00BYTH6121 1,020,847.00 USD 98,047,073.06 96.045  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Equity Income UCITS ETF 28.05.2026 GINC LN IE00BD842Y21 899,606.00 USD 57,523,121.67 63.943  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Opportunities UCITS ETF 28.05.2026 FPX. IE00BYTH6238 200,002.00 USD 14,509,246.50 72.546  ...
-

STLA Deadline: Rosen Law Firm Urges Stellantis N.V. (NYSE: STLA) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of common stock on the New York Stock Exchange (“NYSE”) of Stellantis N.V. (NYSE: STLA) between February 26, 2025 and February 5, 2026. Stellantis describes itself as a “a global automobile designer, engineer, manufacturer, and distributor.”For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653.The Allegat...
-

Young & Co's Brew. UK Regulatory Announcement: Director/PDMR Shareholding

LONDON--(BUSINESS WIRE)--  Young & Co.’s Brewery, P.L.C. (the “Company”) Notifications by PDMRs and persons closely associated with PDMRs Circumstances giving rise to the notifications The Company announces that on 28 May 2026 each of the executive directors listed below have been awarded the following number of the Company’s A ordinary shares of 12.5p each (the ‘A shares’). Name of director Number of A shares awarded Simon Dodd 10,559 Mike Owen 7,391 Tracy Dodd 3,968 This follows the Compa...
-

Virion Therapeutics Reports Progress Towards HBV Functional Cure with Continued HBsAg Declines, Without Rebound, Up to Two Plus Years, After a Single VRON-0200 Dose, From its Phase 1b Study at EASL 2026

PHILADELPHIA--(BUSINESS WIRE)--Virion Therapeutics, LLC, a clinical-stage biotechnology company, developing novel T cell-based immunotherapies that utilize checkpoint modifiers, today announced at the EASL Congress 2026 (The European Association for the Study of the Liver) in Barcelona, Spain, that a single intramuscular dose of VRON-0200, its novel, first-in-class, immunotherapy for HBV Functional Cure, induced HBV-specific immune activation, restoration, and continued HBsAg declines, without...
-

National Association for Veterans Rights Raises Questions About Federal Court Ruling Impacting Veteran Claims Assistance

WASHINGTON--(BUSINESS WIRE)--The National Association for Veterans Rights (NAVR) today responded to the recent district court ruling in Ford v. Veterans Guardian, warning that the decision could significantly disrupt access to lawful assistance for Veterans navigating the VA disability claims process. While the ruling addresses a threshold legal issue and is not a final determination of liability, NAVR believes the Court adopted an overly broad interpretation of federal law, creating substantia...